Question 1

What is MITAPIVAT used for?

Accepted Answer

MITAPIVAT (brand name AQVESME) is a Other indicated for See full prescribing information.

Question 2

How does MITAPIVAT work?

Accepted Answer

MITAPIVAT works through the following mechanism: 12.1 Mechanism of Action Mitapivat is a pyruvate kinase activator that acts by allosterically binding to the pyruvate kinase tetramer and increasing pyruvate kinase (PK) activity. Imbalances in globin chain production during erythropoiesis result in increased oxidative stress, which leads to ineffective erythropoiesis and hemolysis. In nonclinical models of beta-thalassemia, mitapivat improved energy homeostasis, RBC longevity, ineffective erythropoiesis, and hemolysis by increasing PK activity..

Question 3

What are the most common side effects of MITAPIVAT?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for MITAPIVAT. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is MITAPIVAT the same as AQVESME?

Accepted Answer

AQVESME is a brand name for MITAPIVAT. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

MITAPIVAT

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations